Mitochondrial complex I deficiency and ATP/ ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients

Neurological Research

Volumn 34, Issue 3, 2012, Pages 297-303

  Ghiasi, Parisa ^a   Hosseinkhani, Saman ^a   Noori, Alireza ^a   Nafissi, Shahriar ^b   Khajeh, Khosro ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ATP dependent chaperon; Bioluminescence; NADH ferricyanide reductase; Reactive oxygen species

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME DEFICIENCY; FEMALE; HUMAN; LYMPHOCYTE; MALE; PATHOGENESIS;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ELECTRON TRANSPORT COMPLEX I; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 84859338362     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000012     Document Type: Article

References (49)

1. Hervias I, Flint Beal M, Manfredi G. Mitochondrial dysfunction and ALS. Muscle Nerve. 2006;33:598-608.
2. Dupuis L, Gonzalez de Aguilar J-L, Oudart H, de Tapia M, Barbeito L, Loeffler JP. Mitochondria in ALS: a trigger and a target. Neurodegenerative Dis. 2004;1:245-54.
3. Hirano M, Angelini C, Montagna P, Hays AP, Tanji K, Mitsumoto H, et al. Amyotrophic lateral sclerosis with raggedred fibers. Arch Neurol. 2008;65:403-6.
4. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62.
5. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. J Neurol. 1986;361:511-7.
6. Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997;41:210-21.
7. http://alsod.iop.kcl.ac.uk/misc/dataDownload.aspx#C1, 2012 January 10.
8. Syriani E, Morales M, Gamez J. The p. E22G mutation in the Cu/Zn superoxide dismutase gene predicts a long survival time. Neurol Sci. 2009;285:46-53.
9. Luigetti M, Conte A, Madia F, Marangi G, Zollino M, Mancuso I, et al. Heterozygous SOD1 D90Amutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis. Neurol Sci. 2009;30:517-20.
10. Distelmaier F, Koopman WJ, van den Heuvel LP, Rodenburg RJ, Mayatepek E, Willems PH, et al. Mitlochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain. 2009;132:833-42.
11. Pizzuti A, Petrucci S. Mitochondrial disfunction as a cause of ALS. Arch Ital Biol. 2011;149:113-9.
12. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65 Suppl 1:S3-9.
13. Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48:629-41.
14. Vogel RO, Smeitink JA, Nijtmans LG. Human mitochondrial complex I assembly: a dynamic and versatile process. Biochim Biophys Acta. 2007;1767:1215-27.
15. Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1998;156:65-72.
16. Heidari MM, Houshmand M, Hosseinkhani S, Nafissi S, Khatami M. Complex I and ATP content Deficiency in lymphocytes from FRDA. Can J Neurol Sci. 2009;36:26-31.
17. Kumleh HH, Riazi GH, Houshmand M, Sanati MH, Gharagozli K, Shafa M. Complex I deficiency in Persian multiple sclerosis patients. Neurol Sci. 2006;243:65-9.
18. Moosavi SM, Ashtiyani SC, Hosseinkhani S, Shirazi M. Comparison of the effects of L-carnitine and a-tocopherol on acute ureteral obstruction-induced renal oxidative imbalance and altered energy metabolism in rats. Urol Res. 2010;38:187-94.
19. Moosavi SM, Ashtiyani SC, Hosseinkhani S. L-carnitin improves oxidative stress and suppressed energy metabolism but not renal dysfunction following release of acute unilateral obstruction in rat. Neurourol Urodyn. 2011;30:480-7.
20. Wilbourn AJ. Clinical neurophysiology in the diagnosis of ALS: the Lambert and the El Escorial criteria. Neurol Sci. 1998;160:25-9.
21. Friedenauer S, Berlet HH. Sensitivity and variability of the Bradford protein assay in the presence of detergents. Anal Biochem. 1989;178:263-8.
22. Dancey GF, Levine AE, Shapiro BM. The NADH dehydrogenase of the respiratory chain of Escherichia coli. J Biol Chem. 1976;251:5921-8.
23. Dooijewaard G, Slater EC. Steady state kinetics of high molecular weight (type-I) NADH dehydrogenase. Biochim Biophys Acta. 1976;440:1-15.
24. Hatefi Y, Hanstein WG. Interactions of reduced and oxidized triphosphopyridine nucleotides with the electron transport system of bovine heart mitochondria. Biochemistry. 1973; 12:3515-22.
25. Yang NC, Ho WM, Hu ML. A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP. Anal Biochem. 2002;306:323-7.
26. Curti D, Malaspina A, Facchetti G, Camana C, Mazzini L, Tosca P, et al. Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology. 1996;47:1060-4.
27. Reichmann H, Janetzky B, Bischof F, Seibel P, Schols L, Kuhn W, et al. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. Eur Neurol. 1994;34:263-7.
28. Vielhaber S, Winkler K, Kirches E, Kunz D, Büchner M, Feistner H, et al. Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci. 1999;169:133-9.
29. Kish SJ, Bergeron C, Rujput A, Dozic S, Mastrogiacomo F, Chang LJ, et al. Brain cytochrome oxidase in Alzheimers disease. J Neurochem. 1992;59:776-9.
30. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson disease. J Neurochem. 1990;54:823-7.
31. Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB. Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta. 1999;1410:215-28.
32. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in lesions of multiple sclerosis. Neural Sci. 2000;177:95-103.
33. Compston DA, Kellar Wood H, Robertson N, Sawcer S, Wood NW. Genes and susceptibility to multiple sclerosis. Acta Neurol Scand Suppl. 1995;161:43-51.
34. Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol. 1999;46:787-90.
35. Bowling AC, Schulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem. 1993;61:2322-5.
36. Sasaki S, Iwata M. Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett. 1996;204:53-6.
37. Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1984;43:471-80.
38. Beal MF. Mitochondria take center stage in ageing and neurodegeneration. Ann Neurol. 2005;58:495-505.
39. Lenaz G, Bovina C, D'Aurelio M, Fato R, Formiggini G, Genova ML, et al. Role of mitochondria in oxidative stress and ageing. Ann N Y Acad Sci. 2002;959:199-213.
40. Xu JX. Radical metabolism is partner to energy metabolism in mitochondria. Ann NY Acad Sci. 2004;1011:57-60.
41. Duchen MR. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med. 2004; 25:365-451.
42. Koopman WJ, Verkaart S, Visch HJ, van Emst-de Vries S, Nijtmans LG, Smeitink JA, et al. Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology? Am J Physiol Cell Physiol. 2007;293: C22-9.
43. Koopman WJ, Visch HJ, Verkaart S, van den Heuvel LW, Smeitink JA, Willems PH. Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am J Physiol Cell Physiol. 2005;289:C881-90.
44. Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA. 2006;103:2653-8.
45. Mohammadi S, Nikkhah M, Nazari M, Hosseinkhani S. Design of a coupled bioluminescent assay for a recombinant pyruvate kinase from a thermophilic Geobacillus. Photochem Photobiol. 2011;87:1338-45.
46. Wachter C, Schatz G, Glick BS. Protein import into mitochondria: the requirement for external ATP is precursor-specific whereas intramitochondrial ATP is universally needed for translocation into the matrix. Mol Biol Cell. 1994;5: 465-74.
47. Zara V, Ferramosca A, Robitaille-Foucher P, Palmieri F, Young JC. Mitochondrial carrier protein biogenesis: role of the chaperones Hsc70 and Hsp90. Biochem J. 2009;419: 369-75.
48. Garlnad JM, Halestarp A. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J Biol Chem. 1997;272:4680-8.
49. Nakamura N, Wada Y. Properties of DNA fragmentation activity generated by ATP depletion. Cell Death Differ. 2000;7: 477-84.